YNHH to break ground for neuroscience center
Yale New Haven Hospital plans to break ground on its new $838 million neurosciences center at its Saint Raphael campus, two years after delaying the project...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Yale New Haven Hospital plans to break ground on its new $838 million neurosciences center at its Saint Raphael campus, two years after delaying the project...
With the acquisition of Phase 2 ready assets from Cresence AS, Bioasis becomes a clinical stage company with a multi-asset pipeline focused on rare and orphan drugs....
Trevi Therapeutics reports that two late-breaking abstracts have been accepted for presentation at upcoming fall medical conferences. The previously disclosed positive interim data from CANAL, a phase...
A type of tumor called glioblastoma is the most common brain cancer in adults. It’s also one of the most lethal tumor types overall. Only...
View this email in your browser Weekly Roundup – August 25, 2022 Congratulations to ABCT on their recent nomination for the Prix Galien USA Award for Incubators, Accelerators,...
Looking for a job in the biotech industry? Connecticut companies are hiring! Here’s a brief sampling of some open positions. You’ll find them and much...
New Haven-based Precipio, a cancer diagnostics company, has launched new one-step technology that enables same-day test results. Keith Meadors, senior vice president of Precipio’s products division,...
CESI (Center for Education, Simulation, and Innovation) is a world-class, comprehensive medical simulation center on the Hartford Hospital campus that provides experiential education and training services to healthcare providers...
View this email in your browser Career News – August 23, 2022 To register for the University of New Haven’s Fall 2022 Career Expo, go...
Bristol Myers Squibb has completed its acquisition of Turning Point Therapeutics. “Turning Point has distinguished itself in the field of precision oncology, and this acquisition will...